Alcohol use and dementia: A systematic scoping review

Alzheimer's Research and Therapy

Volumn 11, Issue 1, 2019, Pages

  Rehm, Jürgen ^a,b,c,d   Hasan, Omer S M ^a,b   Black, Sandra E ^b,c,e   Shield, Kevin D ^a,b   Schwarzinger, Michaël ^f  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e Sunnybrook Health Sciences Centre   (Canada)

^f Translational Health Economics Network   (France)

Author keywords

Alcohol; Alzheimer's disease; Brain function; Brain volumetrics; Cognition; Dementia; Risk; Systematic review; Vascular dementia

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULTHOOD; ALCOHOL CONSUMPTION; BRAIN FUNCTION; BRAIN SIZE; CAUSAL ATTRIBUTION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; GENETIC VARIATION; HUMAN; PREVENTION STUDY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; WHITE MATTER; ADVERSE EVENT; BRAIN; DIAGNOSTIC IMAGING; DRINKING BEHAVIOR; DRUG EFFECT; META ANALYSIS (TOPIC); PSYCHOLOGY;

ALCOHOL DRINKING; BRAIN; COGNITIVE DYSFUNCTION; DEMENTIA; HUMANS; META-ANALYSIS AS TOPIC; SYSTEMATIC REVIEWS AS TOPIC;

EID: 85059493260     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-018-0453-0     Document Type: Review

References (87)

1. Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673-734.
2. World Health Organization. Dementia: A Public Health priority 2012. Available from: Http://www.who.int/mental-health/publications/dementia-report-2012/en/. Accessed 20 June 2018.
3. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017, 390:1260-344.
4. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dementia. 2013;9:63-75.
5. World Health Organization. Dementia: Fact Sheet 2017. Available from: Http://www.who.int/news-room/fact-sheets/detail/dementia. Accessed 20 June 2018.
6. Alzeimer's Disease International. World Alzheimer Report 2015: The Global Impact of Dementia 2015.
7. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509-38.
8. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89-98.
9. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35(11 suppl 1):2620-2.
10. Oslin D, Atkinson RM, Smith DM, Hendrie H. Alcohol related dementia: Proposed clinical criteria. Int J Geriatr Psychiatry. 1998;13:203-12.
11. Ridley NJ, Draper B, Withall A. Alcohol-related dementia: An update of the evidence. Alzheimers Res Ther. 2013;5:3.
12. Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 2009;44:136-40.
13. Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J, QalyDays Study Group. Contribution of alcohol use disorders to the burden of dementia in France 2008-13: A nationwide retrospective cohort study. Lancet Public Health. 2018;3:e124-e32.
14. Arksey H, O'Malley L. Scoping Studies: Towards a methodological framework. Int J Soc Res Methodol. 2005;8:19-32.
15. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13:141-6.
16. Rehm J, Gmel GE, Gmel G, Hasan OSM, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease- A n update. Addiction. 2017;112:968-1001.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, The Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med. 2009;151:264-9.
18. Alzeimer's Disease International. World Alzheimer Reports: Home page. 2018 Available from: Https://www.alz.co.uk/research/world-report. Accessed 18 June 2018.
19. Haddaway NR, Bayliss HR. Shades of grey: Two forms of grey literature important for reviews in conservation. Biol Conserv. 2015;191:827-9.
20. Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: Meta-analysis of prospective studies. Am J Geriatr Psychiatr. 2009;17:542-55.
21. National Insititute for Health Research. PROSPERO-International prospective register of systematic reviews. York: University of York; 2018.
22. Cheng C, Huang CL, Tsai CJ, Chou PH, Lin CC, Chang CK. Alcohol-related dementia: A systemic review of epidemiological studies. Psychosomatics. 2017;58:331-42.
23. Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors associated with the onset and progression of Alzheimer's disease: A systematic review of the evidence. Neurotoxicology. 2017;61:143-87.
24. Xu W, Wang H, Wan Y, Tan C, Li J, Tan L, et al. Alcohol consumption and dementia risk: A dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32:31-42.
25. Cao L, Tan L, Wang HF, Jiang T, Zhu XC, Tan MS, et al. Dietary patterns and risk of dementia: A systematic review and meta-analysis of cohort studies. Mol Neurobiol. 2016;53:6144-54.
26. Lafortune L, Martin S, Kelly S, Kuhn I, Remes O, Cowan A, et al. Behavioural risk factors in mid-life associated with successful ageing, disability, dementia and frailty in later life: A rapid systematic review. PLoS One. 2016;11:e0144405.
27. Cooper C, Sommerlad A, Lyketsos CG, Livingston G. Modifiable predictors of dementia in mild cognitive impairment: A systematic review and meta-analysis. Am J Psychiatr. 2015;172:323-34.
28. Ilomäki J, Jokanovic N, Tan ECK, Lönnroos E. Alcohol consumption, dementia and cognitive decline: An overview of systematic reviews. Curr Clin Pharmacol. 2015;10:204-12.
29. Thayanukulvat C, Harding T. Binge drinking and cognitive impairment in young people. Br J Nurs. 2015;24:401-7.
30. Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. Meta-analysis of modifiable risk factors for Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2015;86:1299-306.
31. Alzeimer's Disease International. World Alzheimer Report 2014: Dementia and Risk Reduction 2014. Available from: Https://www.alz.co.uk/research/WorldAlzheimerReport2014.pdf. Accessed 15 June 2018.
32. Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: Systematic review and meta-analysis. BMC Public Health. 2014;24:643.
33. Di Marco LY, Marzo A, Munõz-Ruiz M, Ikram MA, Kivipelto M, Ruefenacht D, et al. Modifiable lifestyle factors in dementia: A systematic review of longitudinal observational cohort studies. J Alzheimers Dis. 2014;42:119-35.
34. Pei JJ, Giron MS, Jia J, Wang HX. Dementia studies in Chinese populations. Neurosci Bull. 2014;30:207-16.
35. Amrani L, de Backer L, Dom G. Piekdrinken op jonge leeftijd: Gevolgen voor neurocognitieve functies en genderverschillen [Adolescent binge drinking: Neurocognitive consequences and gender differences]. Tijdschrift voor Psychiatrie. 2013;55:677-89.
36. Monnig MA, Tonigan JS, Yeo RA, Thoma RJ, McCrady BS. White matter volume in alcohol use disorders: A meta-analysis. Addict Biol. 2013;18:581-92.
37. Piazza-Gardner AK, Faffud TJ, Barry AE. The impact of alcohol on Alzheimer's disease: A systematic review. Aging Ment Health. 2013;17:133-46.
38. Montgomery C, Fisk JE, Murphy PN, Ryland I, Hilton J. The effects of heavy social drinking on executive function: A systematic review and meta-analytic study of existing literature and new empirical findings. Human Psychopharmacol. 2012;27:187-99.
39. Buhler M, Mann K. Alcohol and the human brain: A systematic review of different neuroimaging methods. Alcohol Clin Exp Res. 2011;35:1771-93.
40. Neafsey EJ, Collins MA. Moderate alcohol consumption and cognitive risk. Neuropsychiatr Dis Treat. 2011;7:465-84.
41. Lee Y, Back JH, Kim J, Kim SH, Na DL, Cheong HK, et al. Systematic review of health behavioral risks and cognitive health in older adults. 2010;22:174-87.
42. Purnell C, Gao S, Callahan CM, Hendrie HC. Cardiovascular risk factors and incident Alzheimer disease: A systematic review of the literature. Alzheimer Dis Assoc Disord. 2009;23:1-10.
43. Verbaten MN. Chronic effects of low to moderate alcohol consumption on structural and functional propertiesof the brain: Beneficial or not? Human Psychopharmacol. 2009;24:199-205.
44. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: A systematic review. Age Ageing. 2008;37:505-12.
45. Patterson C, Feightner J, Garcia A, MacKnight C. General risk factors for dementia: A systematic evidence review. Alzheimers Dement. 2007;3:341-7.
46. Weih M, Wiltfang J, Kornhuber J. Non-pharmacologic prevention of Alzheimer's disease: Nutritional and life-style risk factors. J Neural Transm (Vienna). 2007;114:1187-97.
47. Reid MC, Boutros NN, O'Connor PG, Cadariu A, Concato J. The health-related effects of alcohol use in older persons: A systematic review. Subst Abus. 2002;23:149-64.
48. World Health Organization. International guide for monitoring alcohol consumption and related harm. Geneva: World Health Organization; 2000.
49. European Medicines Agency. Guideline on the development of medicinal products for the treatment of alcohol dependence. London: European Medicines Agency; 2010.
50. Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106-18.
51. Rasmussen KL, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. Plasma levels of apolipoprotein E and risk of dementia in the general population. Ann Neurol. 2015;77:301-11.
52. Schipper HM. Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment. Neurobiol Aging. 2011;32:778-90.
53. Piano MR. Alcohol's effects on the Cardiovascular system. Alcohol Res. 2017;38:219-41.
54. Rehm J, Room R. The cultural aspect: How to measure and interpret epidemiological data on alcohol use disorders across cultures. Nordic Stud Alcohol Drugs. 2017;34:330-41.
55. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
56. Dufour MC. What is moderate drinking? Alcohol Res Health. 1999;23:5-14.
57. World Health Organization. International guide for monitoring alcohol consumption and related harm. Geneva: World Health Organization; 2000. Available from: Http://apps.who.int/iris/bitstream/handle/10665/66529/WHO-MSD-MSB-00.4.pdf?sequence=1. Accessed 18 June 2018.
58. Fillmore KM, Stockwell T, Chikritzhs T, Bostrom A, Kerr W. Moderate alcohol use and reduced mortality risk: Systematic error in prospective studies and new hypotheses. Ann Epidemiol. 2007;17:S16-23.
59. Shaper A, Wannamethee G, Walker M. Alcohol and mortality in British men: Explaining the U-shaped curve. Lancet. 1988;2:1267-73.
60. Rehm J, Gmel G, Sempos CT, Trevisan M. Methodological issues relevant to studies of alcohol-related morbidity and mortality. Alcohol Res Health. 2003;27:45-7.
61. Binder N, Manderscheid L, Schumacher M. The combined association of alcohol consumption with dementia risk is likely biased due to lacking account of death cases. Eur J Epidemiol. 2017;32:627-9.
62. Shield KD, Gmel G, Gmel GS, Mäkelä P, Probst C, Room R, et al. Lifetime risk of mortality due to different levels of alcohol consumption in seven European countries: Implications for low-risk drinking guidelines. Addiction. 2017;112:1535-44.
63. Topiwala A, Allan CL, Valkanova V, Zsoldos E, Filippini N, Sexton C, et al. Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: Longitudinal cohort study. BMJ. 2017;357:j2353.
64. Sutherland GT, Sheedy D, Kril JJ. Using autopsy brain tissue to study alcohol-related brain damage in the genomic age. Alcohol Clin Exp Res. 2014;38:1-8.
65. Cservenka A, Brumback T. The Burden of Binge and Heavy Drinking on the Brain: Effects on Adolescent and Young Adult Neural Structure and Function. Front Psychol. 2017;8:1111.
66. Kruman II, Henderson GI, Bergeson SE. DNA damage and neurotoxicity of chronic alcohol abuse. Exp Biol Med (Maywood). 2012;237:740-7.
67. National Institute on Alcohol Abuse and Alcoholism. The neurotoxicity of alcohol in department of health and human services, 10th special report to the U.S. Congress on alcohol and health Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2000.
68. Martin PR, Singleton CK, Hiller-Sturmhöfel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health. 2003;27:134-42.
69. Jauhar S, Jane Marshall E, Smith ID. Alcohol and cognitive impairment. Adv Psychiatr Treat. 2014;20:304-13.
70. Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013:Cd004033.
71. Wijdicks EF. Hepatic Encephalopathy. N Engl J Med. 2016;375:1660-70.
72. Samokhvalov AV, Irving H, Mohapatra S, Rehm J. Alcohol consumption, unprovoked seizures and epilepsy: A systematic review and meta-analysis. Epilepsia. 2010;51:1177-84.
73. Taylor LA, Kreutzer JS, Demm SR, Meade MA. Traumatic brain injury and substance abuse: A review and analysis of the literature. Neuropsychol Rehabil. 2003;13:165-88.
74. Schwarzinger M, Thiébaut SP, Baillot S, Mallet V, Rehm J. Alcohol use disorders and associated chronic disease- A national retrospective cohort study from France. BMC Public Health. 2017;18:43.
75. Sabia S, Fayosse A, Dumurgier J, Dugravot A, Akbaraly T, Britton A, et al. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ. 2018;362:k2927.
76. Shield KD, Rehm J. Global risk factor rankings: The importance of age-based health loss inequities caused by alcohol and other risk factors. BMC Res Notes. 2015;8:231.
77. Peterson B, Kristenson H, Sternby NH, Trell E, Fex G, Hood B. Alcohol consumption and premature death in middle-aged men. Br Med J. 1980;280:1403-6.
78. Rehm J, Sulkowska U, Manczuk M, Boffetta P, Powles J, Popova S, et al. Alcohol accounts for a high proportion of premature mortality in central and eastern Europe. Int J Epidemiol. 2007;36:458-67.
79. Smith GD. Mendelian Randomization for Strengthening Causal Inference in Observational Studies: Application to Gene x Environment Interactions. Perspect Psychol Sci. 2010;5:527-45.
80. Frick U, Rehm J. Can we establish causality with statistical analyses? The example of epidemiology. In: Wiedermann W, von Eye A, editors. Statistics and causality: Methods for applied empirical research. Hoboken: Wiley; 2016. p. 407-32.
81. Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS, et al. Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis. BMJ. 2017;359:j5375.
82. Kumari M, Holmes MV, Dale CE, Hubacek JA, Palmer TM, Pikhart H, et al. Alcohol consumption and cognitive performance: A Mendelian randomization study. Addiction. 2014;109:1462-71.
83. Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L. Alcohol consumption and cognitive impairment in older men: A mendelian randomization study. Neurology. 2014;82:1038-44.
84. Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164.
85. Handing EP, Andel R, Kadlecova P, Gatz M, Pedersen NL. Midlife Alcohol Consumption and Risk of Dementia Over 43 Years of Follow-Up: A Population-Based Study From the Swedish Twin Registry. J Gerontol A Biol Sci Med Sci. 2015;70:1248-54.
86. Kaner EF, Beyer FR, Muirhead C, Campbell F, Pienaar ED, Bertholet N, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Revs. 2018;2:CD004148.
87. Rehm J, Anderson P, Manthey J, Shield KD, Struzzo P, Wojnar M, et al. Alcohol Use Disorders in Primary Health Care: What Do We Know and Where Do We Go? Alcohol Alcohol. 2016;51:422-7.